Defibrillator OTC
This article was originally published in The Gray Sheet
Executive Summary
Philips Medical's HeartStart OnSite will join the HeartStart Home as the first defibrillators available to consumers without a prescription beginning in early February. Additional over-the-counter availability will make defibrillators more accessible to communities, schools and businesses for implementing early defibrillation programs, according to the company. Both devices received FDA clearance in September 2004 (1"The Gray Sheet" Sept. 20, 2004, p. 16)...
You may also be interested in...
Philips Gets FDA Nod For First OTC Defibrillator, Plans TV/Print Ad Campaign
Philips Medical expects its HeartStart Home non-prescription AED to become increasingly affordable for consumers as production volume ramps up
US Q1 Consumer Health Earnings Preview: Label This One Historic And Challenging But Promising
US OTC drug and supplement firms’ reports of results for the first three months of 2024 began on April 19 with P&G. JP Morgan analysts say while “some retailers in the US in particular” are reducing consumer health inventories, for the overall sector they expect “a healthier balance of positive volume and lower pricing contribution.”
Keeping Track: Cancer Approvals From Lumisight Imaging To Adjuvant Alecensa
The US FDA’s approval of Lumicell’s optical imaging agent Lumisight makes a dozen novel approvals in 2024 for the Center for Drug Evaluation and Research.